Form 4 for MRNA Moderna
Accepted 2021-10-26 00:00:00 ET · period of report 2021-10-22 · accession 0001127602-21-027654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-26 | 2021-10-22+ | MRNA | Andres Juan | See remarks | M - OptEx | $12.23 | +20.0K | 5,000 | New | +$244.6K |
| DM | 2021-10-26 | 2021-10-22+ | MRNA | Andres Juan | See remarks | S - Sale+OE | $328.77 | -20.0K | 0 | -100% | -$6.58M |
| DM | 2021-10-26 | 2021-10-22+ | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -20.0K | 159.8K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-25 | M | A | 9,822 | $12.21 | 15,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-25 | M | A | 5,000 | $12.21 | 5,178 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-25 | M | A | 178 | $14.22 | 178 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-22 | S | D | 5,000 | $333.00 | 0 | D | — | — | |
| 5 | Common | Common Stock | 2021-10-25 | S | D | 15,000 | $327.36 | 0 | D | — | — | |
| 6 | Common | Common Stock | 2021-10-22 | M | A | 5,000 | $12.21 | 5,000 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-10-25 | M | D | 5,000 | $0.00 | 154,822 | D | $12.21 · — to 2027-08-29 | 5,000 Common Stock | (F2) This option is fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-10-25 | M | D | 178 | $0.00 | 68,629 | D | $14.22 · — to 2028-02-28 | 178 Common Stock | (F3) 25% of this option will vest and become exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-10-25 | M | D | 9,822 | $0.00 | 145,000 | D | $12.21 · — to 2027-08-29 | 9,822 Common Stock | (F2) This option is fully vested and exercisable. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-10-22 | M | D | 5,000 | $0.00 | 159,822 | D | $12.21 · — to 2027-08-29 | 5,000 Common Stock | (F2) This option is fully vested and exercisable. |